Free Trial

Bionano Genomics (BNGO) Insider Trading & Ownership

Bionano Genomics logo
$5.36 +0.02 (+0.37%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$5.28 -0.08 (-1.49%)
As of 02/21/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bionano Genomics (NASDAQ:BNGO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.60%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$92,670.00
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$71,676.00
Get BNGO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bionano Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BNGO Insider Buying and Selling by Quarter

Bionano Genomics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/13/2023Hannah MamuszkaDirectorBuy109$456.00$49,704.00  
5/16/2023R. Erik HolmlinCEOBuy25$384.00$9,600.00  
5/12/2023Christopher P StewartCFOBuy83$402.00$33,366.00  
8/15/2022Yvonne LinneyDirectorSell33$2,172.00$71,676.00  
(Data available from 1/1/2013 forward)

BNGO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bionano Genomics includes Christopher P Stewart, Hannah Mamuszka, R. Erik Holmlin, and Yvonne Linney. Learn more on insiders at BNGO.

1.60% of Bionano Genomics stock is owned by insiders. Learn more on BNGO's insider holdings.

The following insiders have purchased BNGO shares in the last 24 months: Christopher P Stewart ($33,366.00), Hannah Mamuszka ($49,704.00), and R. Erik Holmlin ($9,600.00).

Insiders have purchased a total of 217 BNGO shares in the last 24 months for a total of $92,670.00 bought.

Bionano Genomics Key Executives

  • Dr. Robert Erik Holmlin M.B.A. (Age 56)
    Ph.D., President, CEO & Director
    Compensation: $612.62k
  • Mr. Mark Oldakowski (Age 50)
    Chief Operating Officer
    Compensation: $472.91k
  • Dr. Alka Chaubey FACMG (Age 51)
    Ph.D., Chief Medical Officer
    Compensation: $452.91k
  • Ms. Gulsen Kama M.B.A. (Age 51)
    Chief Financial Officer
  • Mr. Mark Adamchak CPA
    VP of Accounting & Controller
  • Mr. Jonathan Dixon J.D. (Age 49)
    General Counsel & Secretary
  • Mr. Stanislas Marin M.B.A.
    M.S., Vice President of Global Sales
  • Ms. Donna Polizio
    Global Head of Market Access
  • Mr. Cory Kreeck
    Global Head of People Operations
  • Dr. Klint Rose Ph.D.
    Head of Research & Development


This page (NASDAQ:BNGO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners